Transcranial Direct Current Stimulation to Enhance Cognition in Mild Cognitive Impairment

Mild Cognitive Impairment Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01653431
• Other study ID #: HC12381
• Status: Completed
• Phase: Phase 1/Phase 2
• Start date: January 2013
• Est. completion date: November 1, 2019

Study information

• Verified date: February 2020
• Source: The University of New South Wales
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study will examine whether the effects of computerized brain training are enhanced when training is combined with mild brain stimulation in patients with mild cognitive impairment. We hypothesize that this combination will produce greater improvements in cognitive functioning than computerized brain training alone.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 68
• Est. completion date: November 1, 2019
• Est. primary completion date: November 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years to 85 Years

Eligibility

Inclusion Criteria:

• Aged 60 - 85 years.

• Meet diagnostic criteria for amnestic mild cognitive impairment.

Exclusion Criteria:

• Inability to provide informed consent.

• Concurrent medication likely to affect mental performance.

• Current substance use or dependence in last 3 months.

• Current active psychiatric or neurological condition

Related Conditions & MeSH terms

• Cognitive Dysfunction
• Mild Cognitive Impairment

Intervention

Device:
• Transcranial direct current stimulation

Locations

Country	Name	City	State
Australia	Black Dog Institute	Sydney	New South Wales

Sponsors (1)

Lead Sponsor	Collaborator
The University of New South Wales

Country where clinical trial is conducted

Australia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	California Verbal Learning Test II		Post treatment